Motilal Oswal Financial Services recommends Reliance Industries and HCL Tech from the large-cap basket, while BEL and M&M Financial are top bets from mid-cap
Motilal Oswal has initiated coverage on Rubicon Research, a pharmaceutical manufacturing company, with a 'Buy' rating
Ahead of the IPO, the company had allotted over 12.7 million equity shares to 32 funds at ₹485 per share to raise ₹619 crore